Opal BioSciences – Half-year Results
Opal Biosciences Limited – Half-year Financial Report 31 Dec 2017
Infectious disease therapy and vaccine development company BioDiem Ltd and its subsidiary company Opal Biosciences Ltd (“Opal”) are pleased to provide the following information.
Opal Biosciences Limited announces its Information Memorandum
